![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 2, 1383-1390, January 12, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Molecular Biology, Stockholm University,
S-10691 Stockholm, Sweden
We report the cloning and characterization of a
Drosophila proteasome 11 S REG
Identification and Characterization of a Drosophila
Nuclear Proteasome Regulator
A HOMOLOG OF HUMAN 11 S REG
(PA28
)*
, and
(PA28) homolog.
The 28-kDa protein shows 47% identity to the human REG
and strongly
enhances the trypsin-like activities of both Drosophila and
mammalian 20 S proteasomes. Surprisingly, the Drosophila
REG was found to inhibit the proteasome's chymotrypsin-like activity
against the fluorogenic peptide
succinyl-LLVY-7-amino-4-methylcoumarin. Immunocytological
analysis reveals that the Drosophila REG is localized to
the nucleus but is distributed throughout the cell when nuclear
envelope breakdown occurs during mitosis. Through site-directed
mutagenesis studies, we have identified a functional nuclear
localization signal present in the homolog-specific insert region. The
Drosophila PA28 NLS is similar to the oncogene c-Myc nuclear localization motif. Comparison between uninduced and innate immune induced Drosophila cells suggests that the REG
proteasome activator has a role independent of the invertebrate immune
system. Our results support the idea that
class proteasome
activators have an ancient conserved function within metazoans and were
present prior to the emergence of the
and
REG classes.
*
This work was supported by grants from the Swedish Natural
Science Research Council and the Lars Hiertas Trust.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Present address: Dana-Farber Cancer Institute Pediatric Oncology,
M64844 Binney Street Boston, MA 02115.
§
To whom correspondence should be addressed. Tel.: 46-8-164135; Fax:
46-8-152350; E-mail: patrick.young@molbio.su.se.
This article has been cited by other articles:
![]() |
K. Moriishi, R. Mochizuki, K. Moriya, H. Miyamoto, Y. Mori, T. Abe, S. Murata, K. Tanaka, T. Miyamura, T. Suzuki, et al. Critical role of PA28{gamma} in hepatitis C virus-associated steatogenesis and hepatocarcinogenesis PNAS, January 30, 2007; 104(5): 1661 - 1666. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Moriishi, T. Okabayashi, K. Nakai, K. Moriya, K. Koike, S. Murata, T. Chiba, K. Tanaka, R. Suzuki, T. Suzuki, et al. Proteasome Activator PA28{gamma}-Dependent Nuclear Retention and Degradation of Hepatitis C Virus Core Protein J. Virol., October 1, 2003; 77(19): 10237 - 10249. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Okamura, S.-i. Taniguchi, T. Ohkura, A. Yoshida, H. Shimizu, M. Sakai, H. Maeta, H. Fukui, Y. Ueta, I. Hisatome, et al. Abnormally High Expression of Proteasome Activator-{gamma} in Thyroid Neoplasm J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 1374 - 1383. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |